跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIMMYRAH 10 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RIMMYRAH 10 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
RIMMYRAH 10 MG/ML SOLUCION INYECTABLE
Qilu Pharma Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 27, 2024
Approval ID
77c0d82b9b5bb7ec
Company
Qilu Pharma Spain S.L.
Type
Standard
Approval Details
Approval Id
77c0d82b9b5bb7ec
Drug Cima Aemps Name
RIMMYRAH 10 MG/ML SOLUCION INYECTABLE
Register Number
1231779002
Holder Company Name
Qilu Pharma Spain S.L.
Marketing Company Name
Orion Pharma S.L.
Holder Company Detail Path
/organization/qilu-pharma-spain-sl
Authorization Date
2024-03-27
Dosage Form
SOLUCIÓN INYECTABLE
Dose
10 mg/ml
Route Of Administration
VÍA INTRAVÍTREA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Qilu Pharma Spain S.L.
Company Detail Path
/organization/qilu-pharma-spain-sl
Company Information
Pharmaceutical Company Name
QILU PHARMA SPAIN SL.
Country Name
Spain
City Name
madrid,madrid,country_es
Address
PASEO CASTELLANA, 40 - PISO 8
Active Ingredients
RANIBIZUMAB
2,3 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 27, 2024
Approval ID
77c0d82b9b5bb7ec
Type
Standard
Back to CIMA-AEMPS Approvals